Bioprobe Limited in Littlehampton, BN17 5JA

Description

Data updated on: 01-11-2023

Bioprobe came into being in 2014 as a company enlisted under no 08871624, located at BN17 5JA Littlehampton at 41b Beach Road. The company has been in business for ten years and its current status is active. This company's registered with SIC code 72110, that means Research and experimental development on biotechnology. 2022-01-31 is the last time when the company accounts were reported.

To this date, the firm has only been supervised by one managing director: Gregory M. who has been leading it for ten years.

Gregory M. is the individual who controls this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2015-01-31	2016-01-31	2017-01-31	2018-01-31	2019-01-31	2020-01-31	2021-01-31	2022-01-31	2023-01-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	100	-9 751

Balance Sheet
Cash Bank In Hand	100	11 326
Current Assets	100	57 254	65 248	77 600	69 934	50 475	48 549	47 510	46 882
Debtors		45 928
Tangible Fixed Assets		946
Net Assets Liabilities Including Pension Asset Liability	100

Capital & Reserves
Called Up Share Capital	100	100
Profit Loss Account Reserve		-9 851
Shareholder Funds	100	-9 751

Other Financial Data
Amount Specific Advance Or Credit Directors			15 414	31 286	31 556	29 595	27 444	26 652	26 039
Amount Specific Advance Or Credit Made In Period Directors			15 414	15 872	270
Amount Specific Advance Or Credit Repaid In Period Directors						1 961	2 151	792	613
Average Number Employees During Period			1	1	1			1
Creditors		67 951	30 325	48 161	17 291	1 227	492	188	172
Creditors Due Within One Year		67 951
Fixed Assets		946	2 805	2 104	1 578	1 183	888	665	499
Net Current Assets Liabilities	100	-10 697	34 923	29 439	52 643	49 248	48 057	47 322	46 710
Number Shares Allotted		100
Par Value Share		1
Share Capital Allotted Called Up Paid	100	100
Tangible Fixed Assets Additions		1 261
Tangible Fixed Assets Cost Or Valuation		1 261
Tangible Fixed Assets Depreciation		315
Tangible Fixed Assets Depreciation Charged In Period		315
Total Assets Less Current Liabilities	100	-9 751	37 728	31 543	54 221	50 431	48 945	47 987	47 209

Company staff

Gregory M.

Role: Director

Appointed: 31 January 2014

Latest update: 28 April 2024

People with significant control

Gregory M.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

Accounts Documents

Account next due date	31 January 2024
Account last made up date	31 January 2022
Confirmation statement next due date	14 February 2024
Confirmation statement last made up date	31 January 2023

Annual Accounts
Start Date For Period Covered By Report	01 February 2015
End Date For Period Covered By Report	31 January 2016
Annual Accounts
Start Date For Period Covered By Report	01 February 2016
End Date For Period Covered By Report	31 January 2017
Annual Accounts
Start Date For Period Covered By Report	01 February 2017
End Date For Period Covered By Report	31 January 2018
Annual Accounts
Start Date For Period Covered By Report	01 February 2018
End Date For Period Covered By Report	31 January 2019
Annual Accounts
Start Date For Period Covered By Report	01 February 2019
End Date For Period Covered By Report	31 January 2020
Annual Accounts
Start Date For Period Covered By Report	01 February 2020
End Date For Period Covered By Report	31 January 2021
Annual Accounts
Start Date For Period Covered By Report	01 February 2021
End Date For Period Covered By Report	31 January 2022
Annual Accounts
Start Date For Period Covered By Report	01 February 2022
End Date For Period Covered By Report	31 January 2023
Annual Accounts 14 September 2016
Date Approval Accounts	14 September 2016

Bioprobe Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Gregory M.

People with significant control

Gregory M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies